Home Multimedia Podcasts NANOPARTICLE-BASED DRUG DELIVERY AND THERAPY NANOPARTICLE-BASED DRUG DELIVERY AND THERAPY September 6, 2007 – GEN’s Editor-in-Chief John Sterling interviews Alan Crane, CEO, Tempo Pharmaceuticals /wp-content/uploads/2018/09/gc135_9_6_2007.mp3 PodcastsResourcesCancersCombination drug therapyDrug deliveryDrug therapyMedicine, Diagnosis, and TherapeuticsNanoparticlesNanotechnologyPharmacokineticsPharmacologySystemic conditionsTechnology and Computational BiologyTherapeuticsTumorsMillennium Pharmaceuticals
